Status:
RECRUITING
Wearable Activity Tracking to Curb Hospitalizations
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Hematopoietic Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation t...
Detailed Description
PRIMARY OBJECTIVE: I. Validate a previously developed step-count model for predicting all-cause acute care (pooled across all devices). SECONDARY OBJECTIVES: I. Validate a previously developed mode...
Eligibility Criteria
Inclusion
- Age \>= 18.
- Eastern Cooperative Oncology Group (ECOG) performance status =\< 2.
- Able to understand study procedures and to comply with them for the entire length of the study.
- Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
- Diagnosis of invasive malignancy.
- Able to ambulate independently (without the assistance of a cane or walker).
- Planned treatment with fractionated external beam radiotherapy over at least 5 days (no fractional requirement).
- Not a previous participant on this protocol for subsequent courses.
Exclusion
- Participants bound to a wheelchair.
- Participants unable to ambulate independently (needing assistance of cane or walker).
Key Trial Info
Start Date :
April 7 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT06587100
Start Date
April 7 2025
End Date
December 31 2027
Last Update
April 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143